SCHEMBL935285

SCHEMBL935285

Nc1nc(-c2ccccn2)cc2cc([N+](=O)[O-])ccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
GPR35 Q9HC97 1/20 0.57
MAPT P10636 3/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
METAP1 P53582 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
KDM4E B2RXH2 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ABL1 P00519 1/20 0.46
BCR P11274 1/20 0.46
PRKCA P17252 1/20 0.46
F12 P00748 1/20 0.45
GRM5 P41594 1/20 0.44
LMNA P02545 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.42
ADORA3 P0DMS8 1/20 0.41
CLK1 P49759 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11361335 0.82 ADORA3 (0.50) MEN1KMT2AGPR35NPC1RAB9A
SCHEMBL11363871 0.82 ADORA3 (0.50) MEN1KMT2AGPR35NPC1RAB9A
SCHEMBL11367019 0.82 ADORA3 (0.50) MEN1KMT2AGPR35NPC1RAB9A
SCHEMBL10389484 0.77 ADORA3 (0.55) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL13730584 0.77 CCR1 (0.55) MEN1KMT2AGPR35MAPTNPC1
SCHEMBL935201 0.76 CCR1 (0.44) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL935711 0.76 CCR1 (0.56) MEN1KMT2AMAPTNPC1RAB9A
Hydrochloric Acid SCHEMBL11361908 0.75 CCR1 (0.42) MEN1KMT2AMAPTNPC1RAB9A
Hydrochloric Acid SCHEMBL11370119 0.75 CCR1 (0.54) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL12825223 0.75 MEN1 (0.58) MEN1KMT2AGPR35MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011006536-A1 PYRIDYL-SUBSTITUTED ISOQUINOLINE DERIVATIVES WITH ACTIVITY AGAINSTMYCOBACTERIAAND ESPECIALLY MYOBACTERIUM TUBERCULOSIS DAFRA PHARMA N.V. (BE) 2011-01-20 WO disclosed